Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA 1−/2− carriers-Reference-Cited by-同舟云学术

Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA 1−/2− carriers

Published:2018-11-15 Issue:2 Volume:98 Page:250-261
ISSN:0001-6349
Container-title:Acta Obstetricia et Gynecologica Scandinavica
language:en
Short-container-title:Acta Obstet Gynecol Scand

Author:

Ponandai-Srinivasan Sakthivignesh¹^ORCID,Lalitkumar Parameswaran G.¹,Garcia Laura¹,Varghese Suby Jo¹,Carlson Joseph W.²^ORCID,Gemzell-Danielsson Kristina¹^ORCID,Floter Radestad Angelique¹^ORCID

Affiliation:

1. Division of Obstetrics and Gynecology; Department of Women's and Children's Health; Karolinska Institutet and Karolinska University Hospital; Stockholm Sweden

2. Division of Pathology and Cytology; Department of Oncology and Pathology; Karolinska Institutet and Karolinska University Hospital; Stockholm Sweden

Funder

Vetenskapsrådet

Stockholm city county/Karolinska Institutet (ALF).

Publisher

Wiley

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/aogs.13485/fullpdf

Reference49 articles.

1. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study;De Angelis;Lancet Oncol,2014

2. Global Surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2);Allemani;Lancet,2014